Global Deferasirox API Market 2023 by Manufacturers, Regions, Type and Application, Forecast to 2029
Page: 111
Published Date: 11 Jan 2023
Category: Chemical & Material
PDF Download
Get FREE Sample
Customize Request
- Description
- Table of Contents
- Table of Figures
- Research Methodology
- Companies Mentioned
- Related Reports
- Product Tags
Description
Deferasirox is a synthetic, orally bioavailable, achiral, tridentate triazole derived from salicylic acid with iron-chelating activity. Deferasirox chelates iron at a 2:1 (ligand:iron) ratio. Because of its oral availability and long plasma half-life, this agent may be superior to desferrioxamine (desferal, DFO), which is orally inactive and has a short plasma half-life.
According to our (Global Info Research) latest study, the global Deferasirox API market size was valued at USD million in 2022 and is forecast to a readjusted size of USD million by 2029 with a CAGR of % during review period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
This report is a detailed and comprehensive analysis for global Deferasirox API market. Both quantitative and qualitative analyses are presented by manufacturers, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2023, are provided.
Key Features:
Global Deferasirox API market size and forecasts, in consumption value ($ Million), sales quantity (Kiloton), and average selling prices (US$/Ton), 2018-2029
Global Deferasirox API market size and forecasts by region and country, in consumption value ($ Million), sales quantity (Kiloton), and average selling prices (US$/Ton), 2018-2029
Global Deferasirox API market size and forecasts, by Type and by Application, in consumption value ($ Million), sales quantity (Kiloton), and average selling prices (US$/Ton), 2018-2029
Global Deferasirox API market shares of main players, shipments in revenue ($ Million), sales quantity (Kiloton), and ASP (US$/Ton), 2018-2023
The Primary Objectives in This Report Are:
To determine the size of the total market opportunity of global and key countries
To assess the growth potential for Deferasirox API
To forecast future growth in each product and end-use market
To assess competitive factors affecting the marketplace
This report profiles key players in the global Deferasirox API market based on the following parameters - company overview, production, value, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Piramal Enterprises Limited, Alkaloids Corporation, Zhejiang Hengkang Pharmaceutical, Om Pharmaceutical Industries and Teva API, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, COVID-19 and Russia-Ukraine War Influence.
Market Segmentation
Deferasirox API market is split by Type and by Application. For the period 2018-2029, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type
Purity≥98%
Purity<98%
Market segment by Application
Deferasirox Tablets
Others
Major players covered
Piramal Enterprises Limited
Alkaloids Corporation
Zhejiang Hengkang Pharmaceutical
Om Pharmaceutical Industries
Teva API
Symed Labs Limited
Neuland Laboratories
Parabolic Drugs Limited
YUNG ZIP CHEMICAL INDUSTRIAL
Erregierre SpA
Glenmark Pharmaceuticals
Cipla
Sun Pharmaceutical Industries Ltd.
Jubilant Pharma
CTX Lifesciences
Waterstone Pharmaceuticals Inc.
Bal Pharma Ltd.
Curequest Lifescience
Market segment by region, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
South America (Brazil, Argentina, Colombia, and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Deferasirox API product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top manufacturers of Deferasirox API, with price, sales, revenue and global market share of Deferasirox API from 2018 to 2023.
Chapter 3, the Deferasirox API competitive situation, sales quantity, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Deferasirox API breakdown data are shown at the regional level, to show the sales quantity, consumption value and growth by regions, from 2018 to 2029.
Chapter 5 and 6, to segment the sales by Type and application, with sales market share and growth rate by type, application, from 2018 to 2029.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales quantity, consumption value and market share for key countries in the world, from 2017 to 2022.and Deferasirox API market forecast, by regions, type and application, with sales and revenue, from 2024 to 2029.
Chapter 12, market dynamics, drivers, restraints, trends, Porters Five Forces analysis, and Influence of COVID-19 and Russia-Ukraine War.
Chapter 13, the key raw materials and key suppliers, and industry chain of Deferasirox API.
Chapter 14 and 15, to describe Deferasirox API sales channel, distributors, customers, research findings and conclusion.
Table of Contents
1 Market Overview
1.1 Product Overview and Scope of Deferasirox API
1.2 Market Estimation Caveats and Base Year
1.3 Market Analysis by Type
1.3.1 Overview: Global Deferasirox API Consumption Value by Type: 2018 Versus 2022 Versus 2029
1.3.2 Purity≥98%
1.3.3 Purity<98%
1.4 Market Analysis by Application
1.4.1 Overview: Global Deferasirox API Consumption Value by Application: 2018 Versus 2022 Versus 2029
1.4.2 Deferasirox Tablets
1.4.3 Others
1.5 Global Deferasirox API Market Size & Forecast
1.5.1 Global Deferasirox API Consumption Value (2018 & 2022 & 2029)
1.5.2 Global Deferasirox API Sales Quantity (2018-2029)
1.5.3 Global Deferasirox API Average Price (2018-2029)
2 Manufacturers Profiles
2.1 Piramal Enterprises Limited
2.1.1 Piramal Enterprises Limited Details
2.1.2 Piramal Enterprises Limited Major Business
2.1.3 Piramal Enterprises Limited Deferasirox API Product and Services
2.1.4 Piramal Enterprises Limited Deferasirox API Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.1.5 Piramal Enterprises Limited Recent Developments/Updates
2.2 Alkaloids Corporation
2.2.1 Alkaloids Corporation Details
2.2.2 Alkaloids Corporation Major Business
2.2.3 Alkaloids Corporation Deferasirox API Product and Services
2.2.4 Alkaloids Corporation Deferasirox API Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.2.5 Alkaloids Corporation Recent Developments/Updates
2.3 Zhejiang Hengkang Pharmaceutical
2.3.1 Zhejiang Hengkang Pharmaceutical Details
2.3.2 Zhejiang Hengkang Pharmaceutical Major Business
2.3.3 Zhejiang Hengkang Pharmaceutical Deferasirox API Product and Services
2.3.4 Zhejiang Hengkang Pharmaceutical Deferasirox API Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.3.5 Zhejiang Hengkang Pharmaceutical Recent Developments/Updates
2.4 Om Pharmaceutical Industries
2.4.1 Om Pharmaceutical Industries Details
2.4.2 Om Pharmaceutical Industries Major Business
2.4.3 Om Pharmaceutical Industries Deferasirox API Product and Services
2.4.4 Om Pharmaceutical Industries Deferasirox API Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.4.5 Om Pharmaceutical Industries Recent Developments/Updates
2.5 Teva API
2.5.1 Teva API Details
2.5.2 Teva API Major Business
2.5.3 Teva API Deferasirox API Product and Services
2.5.4 Teva API Deferasirox API Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.5.5 Teva API Recent Developments/Updates
2.6 Symed Labs Limited
2.6.1 Symed Labs Limited Details
2.6.2 Symed Labs Limited Major Business
2.6.3 Symed Labs Limited Deferasirox API Product and Services
2.6.4 Symed Labs Limited Deferasirox API Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.6.5 Symed Labs Limited Recent Developments/Updates
2.7 Neuland Laboratories
2.7.1 Neuland Laboratories Details
2.7.2 Neuland Laboratories Major Business
2.7.3 Neuland Laboratories Deferasirox API Product and Services
2.7.4 Neuland Laboratories Deferasirox API Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.7.5 Neuland Laboratories Recent Developments/Updates
2.8 Parabolic Drugs Limited
2.8.1 Parabolic Drugs Limited Details
2.8.2 Parabolic Drugs Limited Major Business
2.8.3 Parabolic Drugs Limited Deferasirox API Product and Services
2.8.4 Parabolic Drugs Limited Deferasirox API Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.8.5 Parabolic Drugs Limited Recent Developments/Updates
2.9 YUNG ZIP CHEMICAL INDUSTRIAL
2.9.1 YUNG ZIP CHEMICAL INDUSTRIAL Details
2.9.2 YUNG ZIP CHEMICAL INDUSTRIAL Major Business
2.9.3 YUNG ZIP CHEMICAL INDUSTRIAL Deferasirox API Product and Services
2.9.4 YUNG ZIP CHEMICAL INDUSTRIAL Deferasirox API Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.9.5 YUNG ZIP CHEMICAL INDUSTRIAL Recent Developments/Updates
2.10 Erregierre SpA
2.10.1 Erregierre SpA Details
2.10.2 Erregierre SpA Major Business
2.10.3 Erregierre SpA Deferasirox API Product and Services
2.10.4 Erregierre SpA Deferasirox API Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.10.5 Erregierre SpA Recent Developments/Updates
2.11 Glenmark Pharmaceuticals
2.11.1 Glenmark Pharmaceuticals Details
2.11.2 Glenmark Pharmaceuticals Major Business
2.11.3 Glenmark Pharmaceuticals Deferasirox API Product and Services
2.11.4 Glenmark Pharmaceuticals Deferasirox API Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.11.5 Glenmark Pharmaceuticals Recent Developments/Updates
2.12 Cipla
2.12.1 Cipla Details
2.12.2 Cipla Major Business
2.12.3 Cipla Deferasirox API Product and Services
2.12.4 Cipla Deferasirox API Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.12.5 Cipla Recent Developments/Updates
2.13 Sun Pharmaceutical Industries Ltd.
2.13.1 Sun Pharmaceutical Industries Ltd. Details
2.13.2 Sun Pharmaceutical Industries Ltd. Major Business
2.13.3 Sun Pharmaceutical Industries Ltd. Deferasirox API Product and Services
2.13.4 Sun Pharmaceutical Industries Ltd. Deferasirox API Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.13.5 Sun Pharmaceutical Industries Ltd. Recent Developments/Updates
2.14 Jubilant Pharma
2.14.1 Jubilant Pharma Details
2.14.2 Jubilant Pharma Major Business
2.14.3 Jubilant Pharma Deferasirox API Product and Services
2.14.4 Jubilant Pharma Deferasirox API Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.14.5 Jubilant Pharma Recent Developments/Updates
2.15 CTX Lifesciences
2.15.1 CTX Lifesciences Details
2.15.2 CTX Lifesciences Major Business
2.15.3 CTX Lifesciences Deferasirox API Product and Services
2.15.4 CTX Lifesciences Deferasirox API Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.15.5 CTX Lifesciences Recent Developments/Updates
2.16 Waterstone Pharmaceuticals Inc.
2.16.1 Waterstone Pharmaceuticals Inc. Details
2.16.2 Waterstone Pharmaceuticals Inc. Major Business
2.16.3 Waterstone Pharmaceuticals Inc. Deferasirox API Product and Services
2.16.4 Waterstone Pharmaceuticals Inc. Deferasirox API Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.16.5 Waterstone Pharmaceuticals Inc. Recent Developments/Updates
2.17 Bal Pharma Ltd.
2.17.1 Bal Pharma Ltd. Details
2.17.2 Bal Pharma Ltd. Major Business
2.17.3 Bal Pharma Ltd. Deferasirox API Product and Services
2.17.4 Bal Pharma Ltd. Deferasirox API Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.17.5 Bal Pharma Ltd. Recent Developments/Updates
2.18 Curequest Lifescience
2.18.1 Curequest Lifescience Details
2.18.2 Curequest Lifescience Major Business
2.18.3 Curequest Lifescience Deferasirox API Product and Services
2.18.4 Curequest Lifescience Deferasirox API Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.18.5 Curequest Lifescience Recent Developments/Updates
3 Competitive Environment: Deferasirox API by Manufacturer
3.1 Global Deferasirox API Sales Quantity by Manufacturer (2018-2023)
3.2 Global Deferasirox API Revenue by Manufacturer (2018-2023)
3.3 Global Deferasirox API Average Price by Manufacturer (2018-2023)
3.4 Market Share Analysis (2022)
3.4.1 Producer Shipments of Deferasirox API by Manufacturer Revenue ($MM) and Market Share (%): 2022
3.4.2 Top 3 Deferasirox API Manufacturer Market Share in 2022
3.4.2 Top 6 Deferasirox API Manufacturer Market Share in 2022
3.5 Deferasirox API Market: Overall Company Footprint Analysis
3.5.1 Deferasirox API Market: Region Footprint
3.5.2 Deferasirox API Market: Company Product Type Footprint
3.5.3 Deferasirox API Market: Company Product Application Footprint
3.6 New Market Entrants and Barriers to Market Entry
3.7 Mergers, Acquisition, Agreements, and Collaborations
4 Consumption Analysis by Region
4.1 Global Deferasirox API Market Size by Region
4.1.1 Global Deferasirox API Sales Quantity by Region (2018-2029)
4.1.2 Global Deferasirox API Consumption Value by Region (2018-2029)
4.1.3 Global Deferasirox API Average Price by Region (2018-2029)
4.2 North America Deferasirox API Consumption Value (2018-2029)
4.3 Europe Deferasirox API Consumption Value (2018-2029)
4.4 Asia-Pacific Deferasirox API Consumption Value (2018-2029)
4.5 South America Deferasirox API Consumption Value (2018-2029)
4.6 Middle East and Africa Deferasirox API Consumption Value (2018-2029)
5 Market Segment by Type
5.1 Global Deferasirox API Sales Quantity by Type (2018-2029)
5.2 Global Deferasirox API Consumption Value by Type (2018-2029)
5.3 Global Deferasirox API Average Price by Type (2018-2029)
6 Market Segment by Application
6.1 Global Deferasirox API Sales Quantity by Application (2018-2029)
6.2 Global Deferasirox API Consumption Value by Application (2018-2029)
6.3 Global Deferasirox API Average Price by Application (2018-2029)
7 North America
7.1 North America Deferasirox API Sales Quantity by Type (2018-2029)
7.2 North America Deferasirox API Sales Quantity by Application (2018-2029)
7.3 North America Deferasirox API Market Size by Country
7.3.1 North America Deferasirox API Sales Quantity by Country (2018-2029)
7.3.2 North America Deferasirox API Consumption Value by Country (2018-2029)
7.3.3 United States Market Size and Forecast (2018-2029)
7.3.4 Canada Market Size and Forecast (2018-2029)
7.3.5 Mexico Market Size and Forecast (2018-2029)
8 Europe
8.1 Europe Deferasirox API Sales Quantity by Type (2018-2029)
8.2 Europe Deferasirox API Sales Quantity by Application (2018-2029)
8.3 Europe Deferasirox API Market Size by Country
8.3.1 Europe Deferasirox API Sales Quantity by Country (2018-2029)
8.3.2 Europe Deferasirox API Consumption Value by Country (2018-2029)
8.3.3 Germany Market Size and Forecast (2018-2029)
8.3.4 France Market Size and Forecast (2018-2029)
8.3.5 United Kingdom Market Size and Forecast (2018-2029)
8.3.6 Russia Market Size and Forecast (2018-2029)
8.3.7 Italy Market Size and Forecast (2018-2029)
9 Asia-Pacific
9.1 Asia-Pacific Deferasirox API Sales Quantity by Type (2018-2029)
9.2 Asia-Pacific Deferasirox API Sales Quantity by Application (2018-2029)
9.3 Asia-Pacific Deferasirox API Market Size by Region
9.3.1 Asia-Pacific Deferasirox API Sales Quantity by Region (2018-2029)
9.3.2 Asia-Pacific Deferasirox API Consumption Value by Region (2018-2029)
9.3.3 China Market Size and Forecast (2018-2029)
9.3.4 Japan Market Size and Forecast (2018-2029)
9.3.5 Korea Market Size and Forecast (2018-2029)
9.3.6 India Market Size and Forecast (2018-2029)
9.3.7 Southeast Asia Market Size and Forecast (2018-2029)
9.3.8 Australia Market Size and Forecast (2018-2029)
10 South America
10.1 South America Deferasirox API Sales Quantity by Type (2018-2029)
10.2 South America Deferasirox API Sales Quantity by Application (2018-2029)
10.3 South America Deferasirox API Market Size by Country
10.3.1 South America Deferasirox API Sales Quantity by Country (2018-2029)
10.3.2 South America Deferasirox API Consumption Value by Country (2018-2029)
10.3.3 Brazil Market Size and Forecast (2018-2029)
10.3.4 Argentina Market Size and Forecast (2018-2029)
11 Middle East & Africa
11.1 Middle East & Africa Deferasirox API Sales Quantity by Type (2018-2029)
11.2 Middle East & Africa Deferasirox API Sales Quantity by Application (2018-2029)
11.3 Middle East & Africa Deferasirox API Market Size by Country
11.3.1 Middle East & Africa Deferasirox API Sales Quantity by Country (2018-2029)
11.3.2 Middle East & Africa Deferasirox API Consumption Value by Country (2018-2029)
11.3.3 Turkey Market Size and Forecast (2018-2029)
11.3.4 Egypt Market Size and Forecast (2018-2029)
11.3.5 Saudi Arabia Market Size and Forecast (2018-2029)
11.3.6 South Africa Market Size and Forecast (2018-2029)
12 Market Dynamics
12.1 Deferasirox API Market Drivers
12.2 Deferasirox API Market Restraints
12.3 Deferasirox API Trends Analysis
12.4 Porters Five Forces Analysis
12.4.1 Threat of New Entrants
12.4.2 Bargaining Power of Suppliers
12.4.3 Bargaining Power of Buyers
12.4.4 Threat of Substitutes
12.4.5 Competitive Rivalry
12.5 Influence of COVID-19 and Russia-Ukraine War
12.5.1 Influence of COVID-19
12.5.2 Influence of Russia-Ukraine War
13 Raw Material and Industry Chain
13.1 Raw Material of Deferasirox API and Key Manufacturers
13.2 Manufacturing Costs Percentage of Deferasirox API
13.3 Deferasirox API Production Process
13.4 Deferasirox API Industrial Chain
14 Shipments by Distribution Channel
14.1 Sales Channel
14.1.1 Direct to End-User
14.1.2 Distributors
14.2 Deferasirox API Typical Distributors
14.3 Deferasirox API Typical Customers
15 Research Findings and Conclusion
16 Appendix
16.1 Methodology
16.2 Research Process and Data Source
16.3 Disclaimer
Table of Figures
List of Tables
Table 1. Global Deferasirox API Consumption Value by Type, (USD Million), 2018 & 2022 & 2029
Table 2. Global Deferasirox API Consumption Value by Application, (USD Million), 2018 & 2022 & 2029
Table 3. Piramal Enterprises Limited Basic Information, Manufacturing Base and Competitors
Table 4. Piramal Enterprises Limited Major Business
Table 5. Piramal Enterprises Limited Deferasirox API Product and Services
Table 6. Piramal Enterprises Limited Deferasirox API Sales Quantity (Kiloton), Average Price (US$/Ton), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 7. Piramal Enterprises Limited Recent Developments/Updates
Table 8. Alkaloids Corporation Basic Information, Manufacturing Base and Competitors
Table 9. Alkaloids Corporation Major Business
Table 10. Alkaloids Corporation Deferasirox API Product and Services
Table 11. Alkaloids Corporation Deferasirox API Sales Quantity (Kiloton), Average Price (US$/Ton), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 12. Alkaloids Corporation Recent Developments/Updates
Table 13. Zhejiang Hengkang Pharmaceutical Basic Information, Manufacturing Base and Competitors
Table 14. Zhejiang Hengkang Pharmaceutical Major Business
Table 15. Zhejiang Hengkang Pharmaceutical Deferasirox API Product and Services
Table 16. Zhejiang Hengkang Pharmaceutical Deferasirox API Sales Quantity (Kiloton), Average Price (US$/Ton), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 17. Zhejiang Hengkang Pharmaceutical Recent Developments/Updates
Table 18. Om Pharmaceutical Industries Basic Information, Manufacturing Base and Competitors
Table 19. Om Pharmaceutical Industries Major Business
Table 20. Om Pharmaceutical Industries Deferasirox API Product and Services
Table 21. Om Pharmaceutical Industries Deferasirox API Sales Quantity (Kiloton), Average Price (US$/Ton), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 22. Om Pharmaceutical Industries Recent Developments/Updates
Table 23. Teva API Basic Information, Manufacturing Base and Competitors
Table 24. Teva API Major Business
Table 25. Teva API Deferasirox API Product and Services
Table 26. Teva API Deferasirox API Sales Quantity (Kiloton), Average Price (US$/Ton), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 27. Teva API Recent Developments/Updates
Table 28. Symed Labs Limited Basic Information, Manufacturing Base and Competitors
Table 29. Symed Labs Limited Major Business
Table 30. Symed Labs Limited Deferasirox API Product and Services
Table 31. Symed Labs Limited Deferasirox API Sales Quantity (Kiloton), Average Price (US$/Ton), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 32. Symed Labs Limited Recent Developments/Updates
Table 33. Neuland Laboratories Basic Information, Manufacturing Base and Competitors
Table 34. Neuland Laboratories Major Business
Table 35. Neuland Laboratories Deferasirox API Product and Services
Table 36. Neuland Laboratories Deferasirox API Sales Quantity (Kiloton), Average Price (US$/Ton), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 37. Neuland Laboratories Recent Developments/Updates
Table 38. Parabolic Drugs Limited Basic Information, Manufacturing Base and Competitors
Table 39. Parabolic Drugs Limited Major Business
Table 40. Parabolic Drugs Limited Deferasirox API Product and Services
Table 41. Parabolic Drugs Limited Deferasirox API Sales Quantity (Kiloton), Average Price (US$/Ton), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 42. Parabolic Drugs Limited Recent Developments/Updates
Table 43. YUNG ZIP CHEMICAL INDUSTRIAL Basic Information, Manufacturing Base and Competitors
Table 44. YUNG ZIP CHEMICAL INDUSTRIAL Major Business
Table 45. YUNG ZIP CHEMICAL INDUSTRIAL Deferasirox API Product and Services
Table 46. YUNG ZIP CHEMICAL INDUSTRIAL Deferasirox API Sales Quantity (Kiloton), Average Price (US$/Ton), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 47. YUNG ZIP CHEMICAL INDUSTRIAL Recent Developments/Updates
Table 48. Erregierre SpA Basic Information, Manufacturing Base and Competitors
Table 49. Erregierre SpA Major Business
Table 50. Erregierre SpA Deferasirox API Product and Services
Table 51. Erregierre SpA Deferasirox API Sales Quantity (Kiloton), Average Price (US$/Ton), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 52. Erregierre SpA Recent Developments/Updates
Table 53. Glenmark Pharmaceuticals Basic Information, Manufacturing Base and Competitors
Table 54. Glenmark Pharmaceuticals Major Business
Table 55. Glenmark Pharmaceuticals Deferasirox API Product and Services
Table 56. Glenmark Pharmaceuticals Deferasirox API Sales Quantity (Kiloton), Average Price (US$/Ton), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 57. Glenmark Pharmaceuticals Recent Developments/Updates
Table 58. Cipla Basic Information, Manufacturing Base and Competitors
Table 59. Cipla Major Business
Table 60. Cipla Deferasirox API Product and Services
Table 61. Cipla Deferasirox API Sales Quantity (Kiloton), Average Price (US$/Ton), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 62. Cipla Recent Developments/Updates
Table 63. Sun Pharmaceutical Industries Ltd. Basic Information, Manufacturing Base and Competitors
Table 64. Sun Pharmaceutical Industries Ltd. Major Business
Table 65. Sun Pharmaceutical Industries Ltd. Deferasirox API Product and Services
Table 66. Sun Pharmaceutical Industries Ltd. Deferasirox API Sales Quantity (Kiloton), Average Price (US$/Ton), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 67. Sun Pharmaceutical Industries Ltd. Recent Developments/Updates
Table 68. Jubilant Pharma Basic Information, Manufacturing Base and Competitors
Table 69. Jubilant Pharma Major Business
Table 70. Jubilant Pharma Deferasirox API Product and Services
Table 71. Jubilant Pharma Deferasirox API Sales Quantity (Kiloton), Average Price (US$/Ton), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 72. Jubilant Pharma Recent Developments/Updates
Table 73. CTX Lifesciences Basic Information, Manufacturing Base and Competitors
Table 74. CTX Lifesciences Major Business
Table 75. CTX Lifesciences Deferasirox API Product and Services
Table 76. CTX Lifesciences Deferasirox API Sales Quantity (Kiloton), Average Price (US$/Ton), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 77. CTX Lifesciences Recent Developments/Updates
Table 78. Waterstone Pharmaceuticals Inc. Basic Information, Manufacturing Base and Competitors
Table 79. Waterstone Pharmaceuticals Inc. Major Business
Table 80. Waterstone Pharmaceuticals Inc. Deferasirox API Product and Services
Table 81. Waterstone Pharmaceuticals Inc. Deferasirox API Sales Quantity (Kiloton), Average Price (US$/Ton), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 82. Waterstone Pharmaceuticals Inc. Recent Developments/Updates
Table 83. Bal Pharma Ltd. Basic Information, Manufacturing Base and Competitors
Table 84. Bal Pharma Ltd. Major Business
Table 85. Bal Pharma Ltd. Deferasirox API Product and Services
Table 86. Bal Pharma Ltd. Deferasirox API Sales Quantity (Kiloton), Average Price (US$/Ton), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 87. Bal Pharma Ltd. Recent Developments/Updates
Table 88. Curequest Lifescience Basic Information, Manufacturing Base and Competitors
Table 89. Curequest Lifescience Major Business
Table 90. Curequest Lifescience Deferasirox API Product and Services
Table 91. Curequest Lifescience Deferasirox API Sales Quantity (Kiloton), Average Price (US$/Ton), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 92. Curequest Lifescience Recent Developments/Updates
Table 93. Global Deferasirox API Sales Quantity by Manufacturer (2018-2023) & (Kiloton)
Table 94. Global Deferasirox API Revenue by Manufacturer (2018-2023) & (USD Million)
Table 95. Global Deferasirox API Average Price by Manufacturer (2018-2023) & (US$/Ton)
Table 96. Market Position of Manufacturers in Deferasirox API, (Tier 1, Tier 2, and Tier 3), Based on Consumption Value in 2022
Table 97. Head Office and Deferasirox API Production Site of Key Manufacturer
Table 98. Deferasirox API Market: Company Product Type Footprint
Table 99. Deferasirox API Market: Company Product Application Footprint
Table 100. Deferasirox API New Market Entrants and Barriers to Market Entry
Table 101. Deferasirox API Mergers, Acquisition, Agreements, and Collaborations
Table 102. Global Deferasirox API Sales Quantity by Region (2018-2023) & (Kiloton)
Table 103. Global Deferasirox API Sales Quantity by Region (2024-2029) & (Kiloton)
Table 104. Global Deferasirox API Consumption Value by Region (2018-2023) & (USD Million)
Table 105. Global Deferasirox API Consumption Value by Region (2024-2029) & (USD Million)
Table 106. Global Deferasirox API Average Price by Region (2018-2023) & (US$/Ton)
Table 107. Global Deferasirox API Average Price by Region (2024-2029) & (US$/Ton)
Table 108. Global Deferasirox API Sales Quantity by Type (2018-2023) & (Kiloton)
Table 109. Global Deferasirox API Sales Quantity by Type (2024-2029) & (Kiloton)
Table 110. Global Deferasirox API Consumption Value by Type (2018-2023) & (USD Million)
Table 111. Global Deferasirox API Consumption Value by Type (2024-2029) & (USD Million)
Table 112. Global Deferasirox API Average Price by Type (2018-2023) & (US$/Ton)
Table 113. Global Deferasirox API Average Price by Type (2024-2029) & (US$/Ton)
Table 114. Global Deferasirox API Sales Quantity by Application (2018-2023) & (Kiloton)
Table 115. Global Deferasirox API Sales Quantity by Application (2024-2029) & (Kiloton)
Table 116. Global Deferasirox API Consumption Value by Application (2018-2023) & (USD Million)
Table 117. Global Deferasirox API Consumption Value by Application (2024-2029) & (USD Million)
Table 118. Global Deferasirox API Average Price by Application (2018-2023) & (US$/Ton)
Table 119. Global Deferasirox API Average Price by Application (2024-2029) & (US$/Ton)
Table 120. North America Deferasirox API Sales Quantity by Type (2018-2023) & (Kiloton)
Table 121. North America Deferasirox API Sales Quantity by Type (2024-2029) & (Kiloton)
Table 122. North America Deferasirox API Sales Quantity by Application (2018-2023) & (Kiloton)
Table 123. North America Deferasirox API Sales Quantity by Application (2024-2029) & (Kiloton)
Table 124. North America Deferasirox API Sales Quantity by Country (2018-2023) & (Kiloton)
Table 125. North America Deferasirox API Sales Quantity by Country (2024-2029) & (Kiloton)
Table 126. North America Deferasirox API Consumption Value by Country (2018-2023) & (USD Million)
Table 127. North America Deferasirox API Consumption Value by Country (2024-2029) & (USD Million)
Table 128. Europe Deferasirox API Sales Quantity by Type (2018-2023) & (Kiloton)
Table 129. Europe Deferasirox API Sales Quantity by Type (2024-2029) & (Kiloton)
Table 130. Europe Deferasirox API Sales Quantity by Application (2018-2023) & (Kiloton)
Table 131. Europe Deferasirox API Sales Quantity by Application (2024-2029) & (Kiloton)
Table 132. Europe Deferasirox API Sales Quantity by Country (2018-2023) & (Kiloton)
Table 133. Europe Deferasirox API Sales Quantity by Country (2024-2029) & (Kiloton)
Table 134. Europe Deferasirox API Consumption Value by Country (2018-2023) & (USD Million)
Table 135. Europe Deferasirox API Consumption Value by Country (2024-2029) & (USD Million)
Table 136. Asia-Pacific Deferasirox API Sales Quantity by Type (2018-2023) & (Kiloton)
Table 137. Asia-Pacific Deferasirox API Sales Quantity by Type (2024-2029) & (Kiloton)
Table 138. Asia-Pacific Deferasirox API Sales Quantity by Application (2018-2023) & (Kiloton)
Table 139. Asia-Pacific Deferasirox API Sales Quantity by Application (2024-2029) & (Kiloton)
Table 140. Asia-Pacific Deferasirox API Sales Quantity by Region (2018-2023) & (Kiloton)
Table 141. Asia-Pacific Deferasirox API Sales Quantity by Region (2024-2029) & (Kiloton)
Table 142. Asia-Pacific Deferasirox API Consumption Value by Region (2018-2023) & (USD Million)
Table 143. Asia-Pacific Deferasirox API Consumption Value by Region (2024-2029) & (USD Million)
Table 144. South America Deferasirox API Sales Quantity by Type (2018-2023) & (Kiloton)
Table 145. South America Deferasirox API Sales Quantity by Type (2024-2029) & (Kiloton)
Table 146. South America Deferasirox API Sales Quantity by Application (2018-2023) & (Kiloton)
Table 147. South America Deferasirox API Sales Quantity by Application (2024-2029) & (Kiloton)
Table 148. South America Deferasirox API Sales Quantity by Country (2018-2023) & (Kiloton)
Table 149. South America Deferasirox API Sales Quantity by Country (2024-2029) & (Kiloton)
Table 150. South America Deferasirox API Consumption Value by Country (2018-2023) & (USD Million)
Table 151. South America Deferasirox API Consumption Value by Country (2024-2029) & (USD Million)
Table 152. Middle East & Africa Deferasirox API Sales Quantity by Type (2018-2023) & (Kiloton)
Table 153. Middle East & Africa Deferasirox API Sales Quantity by Type (2024-2029) & (Kiloton)
Table 154. Middle East & Africa Deferasirox API Sales Quantity by Application (2018-2023) & (Kiloton)
Table 155. Middle East & Africa Deferasirox API Sales Quantity by Application (2024-2029) & (Kiloton)
Table 156. Middle East & Africa Deferasirox API Sales Quantity by Region (2018-2023) & (Kiloton)
Table 157. Middle East & Africa Deferasirox API Sales Quantity by Region (2024-2029) & (Kiloton)
Table 158. Middle East & Africa Deferasirox API Consumption Value by Region (2018-2023) & (USD Million)
Table 159. Middle East & Africa Deferasirox API Consumption Value by Region (2024-2029) & (USD Million)
Table 160. Deferasirox API Raw Material
Table 161. Key Manufacturers of Deferasirox API Raw Materials
Table 162. Deferasirox API Typical Distributors
Table 163. Deferasirox API Typical Customers
List of Figures
Figure 1. Deferasirox API Picture
Figure 2. Global Deferasirox API Consumption Value by Type, (USD Million), 2018 & 2022 & 2029
Figure 3. Global Deferasirox API Consumption Value Market Share by Type in 2022
Figure 4. Purity≥98% Examples
Figure 5. Purity<98% Examples
Figure 6. Global Deferasirox API Consumption Value by Application, (USD Million), 2018 & 2022 & 2029
Figure 7. Global Deferasirox API Consumption Value Market Share by Application in 2022
Figure 8. Deferasirox Tablets Examples
Figure 9. Others Examples
Figure 10. Global Deferasirox API Consumption Value, (USD Million): 2018 & 2022 & 2029
Figure 11. Global Deferasirox API Consumption Value and Forecast (2018-2029) & (USD Million)
Figure 12. Global Deferasirox API Sales Quantity (2018-2029) & (Kiloton)
Figure 13. Global Deferasirox API Average Price (2018-2029) & (US$/Ton)
Figure 14. Global Deferasirox API Sales Quantity Market Share by Manufacturer in 2022
Figure 15. Global Deferasirox API Consumption Value Market Share by Manufacturer in 2022
Figure 16. Producer Shipments of Deferasirox API by Manufacturer Sales Quantity ($MM) and Market Share (%): 2021
Figure 17. Top 3 Deferasirox API Manufacturer (Consumption Value) Market Share in 2022
Figure 18. Top 6 Deferasirox API Manufacturer (Consumption Value) Market Share in 2022
Figure 19. Global Deferasirox API Sales Quantity Market Share by Region (2018-2029)
Figure 20. Global Deferasirox API Consumption Value Market Share by Region (2018-2029)
Figure 21. North America Deferasirox API Consumption Value (2018-2029) & (USD Million)
Figure 22. Europe Deferasirox API Consumption Value (2018-2029) & (USD Million)
Figure 23. Asia-Pacific Deferasirox API Consumption Value (2018-2029) & (USD Million)
Figure 24. South America Deferasirox API Consumption Value (2018-2029) & (USD Million)
Figure 25. Middle East & Africa Deferasirox API Consumption Value (2018-2029) & (USD Million)
Figure 26. Global Deferasirox API Sales Quantity Market Share by Type (2018-2029)
Figure 27. Global Deferasirox API Consumption Value Market Share by Type (2018-2029)
Figure 28. Global Deferasirox API Average Price by Type (2018-2029) & (US$/Ton)
Figure 29. Global Deferasirox API Sales Quantity Market Share by Application (2018-2029)
Figure 30. Global Deferasirox API Consumption Value Market Share by Application (2018-2029)
Figure 31. Global Deferasirox API Average Price by Application (2018-2029) & (US$/Ton)
Figure 32. North America Deferasirox API Sales Quantity Market Share by Type (2018-2029)
Figure 33. North America Deferasirox API Sales Quantity Market Share by Application (2018-2029)
Figure 34. North America Deferasirox API Sales Quantity Market Share by Country (2018-2029)
Figure 35. North America Deferasirox API Consumption Value Market Share by Country (2018-2029)
Figure 36. United States Deferasirox API Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 37. Canada Deferasirox API Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 38. Mexico Deferasirox API Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 39. Europe Deferasirox API Sales Quantity Market Share by Type (2018-2029)
Figure 40. Europe Deferasirox API Sales Quantity Market Share by Application (2018-2029)
Figure 41. Europe Deferasirox API Sales Quantity Market Share by Country (2018-2029)
Figure 42. Europe Deferasirox API Consumption Value Market Share by Country (2018-2029)
Figure 43. Germany Deferasirox API Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 44. France Deferasirox API Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 45. United Kingdom Deferasirox API Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 46. Russia Deferasirox API Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 47. Italy Deferasirox API Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 48. Asia-Pacific Deferasirox API Sales Quantity Market Share by Type (2018-2029)
Figure 49. Asia-Pacific Deferasirox API Sales Quantity Market Share by Application (2018-2029)
Figure 50. Asia-Pacific Deferasirox API Sales Quantity Market Share by Region (2018-2029)
Figure 51. Asia-Pacific Deferasirox API Consumption Value Market Share by Region (2018-2029)
Figure 52. China Deferasirox API Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 53. Japan Deferasirox API Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 54. Korea Deferasirox API Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 55. India Deferasirox API Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 56. Southeast Asia Deferasirox API Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 57. Australia Deferasirox API Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 58. South America Deferasirox API Sales Quantity Market Share by Type (2018-2029)
Figure 59. South America Deferasirox API Sales Quantity Market Share by Application (2018-2029)
Figure 60. South America Deferasirox API Sales Quantity Market Share by Country (2018-2029)
Figure 61. South America Deferasirox API Consumption Value Market Share by Country (2018-2029)
Figure 62. Brazil Deferasirox API Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 63. Argentina Deferasirox API Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 64. Middle East & Africa Deferasirox API Sales Quantity Market Share by Type (2018-2029)
Figure 65. Middle East & Africa Deferasirox API Sales Quantity Market Share by Application (2018-2029)
Figure 66. Middle East & Africa Deferasirox API Sales Quantity Market Share by Region (2018-2029)
Figure 67. Middle East & Africa Deferasirox API Consumption Value Market Share by Region (2018-2029)
Figure 68. Turkey Deferasirox API Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 69. Egypt Deferasirox API Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 70. Saudi Arabia Deferasirox API Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 71. South Africa Deferasirox API Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 72. Deferasirox API Market Drivers
Figure 73. Deferasirox API Market Restraints
Figure 74. Deferasirox API Market Trends
Figure 75. Porters Five Forces Analysis
Figure 76. Manufacturing Cost Structure Analysis of Deferasirox API in 2022
Figure 77. Manufacturing Process Analysis of Deferasirox API
Figure 78. Deferasirox API Industrial Chain
Figure 79. Sales Quantity Channel: Direct to End-User vs Distributors
Figure 80. Direct Channel Pros & Cons
Figure 81. Indirect Channel Pros & Cons
Figure 82. Methodology
Figure 83. Research Process and Data Source
Research Methodology
Client Requirements
Review and analyze client requirements
Discussion of all the project requirements and queries
Flexibility Check
Project Feasibility Analysis
Finalizing tentative research programme
Structuring project proposal with scope, timeline, and costs
Analyzing Market Dynamics
Determination of key drivers, restraints, challenge, and opportunity
Identifies market needs and trends
Market Size Estimation & Forecast
Estimation of historical data based on secondary and primary data
Anticipating market recast by assigning weightage to market forces (drivers, restraints, opportunities)
Freezing historical and forecast market size estimations based on evolution, trends, outlook, and strategies
Consideration of geography, region-specific product/service demand for region segments
Consideration of product utilization rates, product demand outlook for segments by application or end-user.
Data Source
Secondary Source
Data collections from annual reports, presentations,associations, journals, analyst reports,
paid database, press releases, blogs, newsletters,and GIR repositories.
Primary Source
Research discussion with manufacturers, distributors, suppliers, end user, industry experts
to verify insights.
Validation
and
triangulation of
secondary and primary source.
Collection of data
Cumulating and collating the essential qualitative and quantitative data
Generation of report in client requested format by research analysts
Reviews by expert analysts
Final quality check
Clarifying queries
Receiving feedback
Ensuring satisfaction
01 Identification of data
This step involves identification of several primary and secondary data research sources, including Global Info Research's internal data sources. The primary sources consist of in-depth discussions and interviews with policy makers, industry experts, and data evaluators, whereas secondary sources include a thorough study of market journals, press releases, annual reports, and government and non-government agencies websites.
02 Evaluation of Market Dynamic
This phase includes a detailed evaluation of several factors that are likely to affect the market dynamics. It involves a comprehensive assessment of major market pain points, drivers, and trends. It also comprises a detailed study of research plans and methodology.
03 Collection of Data
This process consists of gathering data, accessing proprietary databases, and reaching out to key industry participants that operate in the market across the value chain. It also involves studying several patterns in the historical data and comparing it with the current scenario.
04 Collaboration of Data
This stage involves the validation of data and arrival at actual statistics, and evolution of the market over the years. It entails the study and analyzes various segments and verticals of the market. An impact analysis is also performed to observe which factors will affect the market in the next few years.
05 Verification and Analysis
This is the final stage, which involves both quantity and quality checks. Although the process of data verification is an integral part of the research process, all data points and statistics and figures are re-checked to uphold their authenticity and validity.
Companies Mentioned
Piramal Enterprises Limited Alkaloids Corporation Zhejiang Hengkang Pharmaceutical Om Pharmaceutical Industries Teva API Symed Labs Limited Neuland Laboratories Parabolic Drugs Limited YUNG ZIP CHEMICAL INDUSTRIAL Erregierre SpA Glenmark Pharmaceuticals Cipla Sun Pharmaceutical Industries Ltd. Jubilant Pharma CTX Lifesciences Waterstone Pharmaceuticals Inc. Bal Pharma Ltd. Curequest Lifescience
Related Reports
Product Tags
Purchase Options
Add To Cart
Buy Now
Popular Product Keywords
- We Provide Professional, Accurate Market Analysis to Help You Stay Ahead of Your Competition.Speak to our analyst >>
Our Clients
What We Can Provide?
With better results and higher quality products,Our professional reports can achieve four things:
-
Insight into the industry market information
-
Analyze market development needs
-
Prospects for future development
-
Develop industry investment strategy
-
- Digging deeper into global industry information and providing market strategies.Contact Us >>